1. RetinAI establishes presence in the US market

    RetinAI establishes presence in the US market

    Founded in 2017, RetinAI develops software solutions for experts in ophthalmology to accelerate clinical, research and pharmaceutical workflows globally using advanced machine learning and computer vision. Its CE-marked data management platform (RetinAI Discovery) and models, including AI models for Geographic Atrophy progression prediction, analyse datasets at-scale to gain a deep understanding on biomarker profiles and patient subgroups or outcomes. Building on its success in Switzerland, the company is now setting foot in the US with an office in Boston. This expansion will support further growth within the U.S. market, building upon existing collaborations with U.S.-based pharmaceutical companies ...

    Read Full Article

    Login to comment.

  1. Categories

    1. Applications:

      Art, Cardiology, Dentistry, Dermatology, Developmental Biology, Gastroenterology, Gynecology, Microscopy, NDE/NDT, Neurology, Oncology, Ophthalmology, Other Non-Medical, Otolaryngology, Pulmonology, Urology
    2. Business News:

      Acquisition, Clinical Trials, Funding, Other Business News, Partnership, Patents
    3. Technology:

      Broadband Sources, Probes, Tunable Sources
    4. Miscellaneous:

      Jobs & Studentships, Student Theses, Textbooks
  2. Quotes

    1. Our team is delighted about this natural expansion into the U.S..
  3. Topics Mentioned